{
    "startDate": "2019-01-01",
    "endDate": "2019-06-30",
    "year": "2019",
    "quarter": "Q2",
    "symbol": "AMRX",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents - end of period",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 54893000
            },
            {
                "label": "Restricted cash - end of period",
                "concept": "RestrictedCashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 2129000
            },
            {
                "label": "Trade accounts receivable, net",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 634666000
            },
            {
                "label": "Total inventories",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 414627000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 77062000
            },
            {
                "label": "Related party receivables",
                "concept": "DueFromRelatedPartiesCurrent",
                "unit": "usd",
                "value": 2470000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 1185847000
            },
            {
                "label": "Property, plant and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 508086000
            },
            {
                "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 420017000
            },
            {
                "label": "Intangible assets, net",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 1553330000
            },
            {
                "label": "Deferred tax asset, net",
                "concept": "DeferredIncomeTaxAssetsNet",
                "unit": "usd",
                "value": 391881000
            },
            {
                "label": "Operating lease right-of-use assets",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 76931000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 63459000
            },
            {
                "label": "Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 4262139000
            },
            {
                "label": "Transition contract liability",
                "concept": "AccountsPayableAndAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 505143000
            },
            {
                "label": "Current portion of long-term debt, net",
                "concept": "LongTermDebtAndCapitalLeaseObligationsCurrent",
                "unit": "usd",
                "value": 21445000
            },
            {
                "label": "Related party payables",
                "concept": "DueToRelatedPartiesCurrent",
                "unit": "usd",
                "value": 2965000
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 546159000
            },
            {
                "label": "Long-term debt, net",
                "concept": "LongTermDebtNoncurrent",
                "unit": "usd",
                "value": 2619788000
            },
            {
                "label": "Deferred income taxes",
                "concept": "DeferredIncomeTaxLiabilitiesNet",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Liabilities under tax receivable agreement",
                "concept": "amrx:LiabilitiesUnderTaxReceivableAgreementNoncurrent",
                "unit": "usd",
                "value": 193499000
            },
            {
                "label": "Other liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 28653000
            },
            {
                "label": "Total long-term liabilities",
                "concept": "LiabilitiesNoncurrent",
                "unit": "usd",
                "value": 2966628000
            },
            {
                "label": "Commitments and Contingencies Disclosure [Abstract]",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Preferred stock, $0.01 par value, 2,000 shares authorized; none issued at both June 30, 2019 and December 31, 2018",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Additional Paid-in Capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 544161000
            },
            {
                "label": "Stockholders' accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -80746000
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -6750000
            },
            {
                "label": "Stockholders' equity beginning balance",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 459656000
            },
            {
                "label": "Ownership percentage by noncontrolling owners",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": 289696000
            },
            {
                "label": "Stockholders' equity beginning balance",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 749352000
            },
            {
                "label": "Liabilities and Stockholders' Equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 4262139000
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -175278000
            },
            {
                "label": "Depreciation and amortization",
                "concept": "amrx:DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts",
                "unit": "usd",
                "value": 99574000
            },
            {
                "label": "Amortization of Levothyroxine Transition Agreement asset",
                "concept": "amrx:AmortizationTransitionAgreementPayment",
                "unit": "usd",
                "value": 36393000
            },
            {
                "label": "Unrealized foreign currency (gain) loss",
                "concept": "ForeignCurrencyTransactionGainLossUnrealized",
                "unit": "usd",
                "value": 3695000
            },
            {
                "label": "Amortization of debt issuance costs",
                "concept": "AmortizationOfFinancingCosts",
                "unit": "usd",
                "value": 3218000
            },
            {
                "label": "Loss on extinguishment of debt",
                "concept": "GainsLossesOnExtinguishmentOfDebt",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "(Loss) gain on sale of international businesses, net",
                "concept": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
                "unit": "usd",
                "value": 6930000
            },
            {
                "label": "Gain on termination of lease",
                "concept": "GainLossOnContractTermination",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Intangible asset impairment charges",
                "concept": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
                "unit": "usd",
                "value": 79096000
            },
            {
                "label": "Non-cash restructuring and asset-related charges",
                "concept": "amrx:NoncashRestructuringCostsAndAssetImpairmentCharges",
                "unit": "usd",
                "value": 1314000
            },
            {
                "label": "Deferred tax benefit",
                "concept": "DeferredIncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": -18209000
            },
            {
                "label": "Stock-based compensation and PPU expense",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 10571000
            },
            {
                "label": "Inventory provision",
                "concept": "InventoryWriteDown",
                "unit": "usd",
                "value": 50410000
            },
            {
                "label": "Other operating charges and credits, net",
                "concept": "OtherNoncashIncomeExpense",
                "unit": "usd",
                "value": -3155000
            },
            {
                "label": "Trade accounts receivable, net",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": 162954000
            },
            {
                "label": "Inventories",
                "concept": "IncreaseDecreaseInInventories",
                "unit": "usd",
                "value": 19658000
            },
            {
                "label": "Prepaid expenses, other current assets and other assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": -28614000
            },
            {
                "label": "Related party receivables",
                "concept": "IncreaseDecreaseInDueFromRelatedParties",
                "unit": "usd",
                "value": 1624000
            },
            {
                "label": "Accounts payable, accrued expenses and other liabilities",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": -13538000
            },
            {
                "label": "Related party payables",
                "concept": "IncreaseDecreaseInDueToRelatedParties",
                "unit": "usd",
                "value": 2225000
            },
            {
                "label": "Cash flows from operating activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -87316000
            },
            {
                "label": "Purchases of property, plant and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 29629000
            },
            {
                "label": "Acquisition of product rights and licenses",
                "concept": "PaymentsToAcquireIntangibleAssets",
                "unit": "usd",
                "value": 50000000
            },
            {
                "label": "Acquisitions, net of cash acquired",
                "concept": "PaymentsToAcquireBusinessesNetOfCashAcquired",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Proceeds from sale of international businesses, net of cash sold",
                "concept": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
                "unit": "usd",
                "value": 34834000
            },
            {
                "label": "Cash flows from investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -44795000
            },
            {
                "label": "Payments of deferred financing costs and debt extinguishment costs",
                "concept": "PaymentsOfFinancingCosts",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Proceeds from issuance of debt",
                "concept": "ProceedsFromIssuanceOfMediumTermNotes",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Payments of principal on debt and capital leases",
                "concept": "RepaymentsOfLongTermCapitalLeaseObligations",
                "unit": "usd",
                "value": 13500000
            },
            {
                "label": "Payments on revolving credit line",
                "concept": "RepaymentsOfLinesOfCredit",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Proceeds from exercise of stock options",
                "concept": "ProceedsFromStockOptionsExercised",
                "unit": "usd",
                "value": 1385000
            },
            {
                "label": "Employee payroll tax withholding on restricted stock unit vesting",
                "concept": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "unit": "usd",
                "value": 921000
            },
            {
                "label": "Equity contributions",
                "concept": "ProceedsFromContributedCapital",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Capital contribution from non-controlling interest",
                "concept": "ProceedsFromMinorityShareholders",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Acquisition of non-controlling interest",
                "concept": "amrx:PaymentsForRepurchaseOfNoncontrollingInterest",
                "unit": "usd",
                "value": 3543000
            },
            {
                "label": "Tax distribution to non-controlling interest",
                "concept": "amrx:TaxDistributionToNoncontrollingInterestFinancingActivities",
                "unit": "usd",
                "value": 13494000
            },
            {
                "label": "Distributions to members",
                "concept": "PaymentsOfDividends",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Financing cash flows from finance leases",
                "concept": "FinanceLeasePrincipalPayments",
                "unit": "usd",
                "value": 866000
            },
            {
                "label": "Repayment of related party note",
                "concept": "RepaymentsOfRelatedPartyDebt",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Cash flows from financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": -30939000
            },
            {
                "label": "Effect of foreign exchange rate on cash",
                "concept": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                "unit": "usd",
                "value": 1293000
            },
            {
                "label": "Net decrease in cash, cash equivalents, and restricted cash",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": -161757000
            },
            {
                "label": "Cash paid for interest",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": 81103000
            },
            {
                "label": "Cash received for income taxes",
                "concept": "IncomeTaxesPaidNet",
                "unit": "usd",
                "value": 8533000
            },
            {
                "label": "Payable for acquisition of product rights and licenses",
                "concept": "FairValueOfAssetsAcquired",
                "unit": "usd",
                "value": 0
            }
        ],
        "ic": [
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -175278000
            },
            {
                "label": "Less: Net loss attributable to Amneal Pharmaceuticals LLC pre-Combination",
                "concept": "amrx:NetIncomeLossAttributableToAcquirerPriorToBusinessCombination",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Less: Net loss attributable to non-controlling interests",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -110495000
            },
            {
                "label": "Numerator:",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -64783000
            },
            {
                "label": "Accretion of redeemable non-controlling interest",
                "concept": "TemporaryEquityAccretionToRedemptionValueAdjustment",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Numerator:",
                "concept": "NetIncomeLossAvailableToCommonStockholdersBasic",
                "unit": "usd",
                "value": -64783000
            },
            {
                "label": "Foreign currency translation adjustments arising during the period",
                "concept": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": -983000
            },
            {
                "label": "Less: Reclassification of foreign currency translation adjustment included in net loss",
                "concept": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax",
                "unit": "usd",
                "value": -3413000
            },
            {
                "label": "Foreign currency translation adjustments, net",
                "concept": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
                "unit": "usd",
                "value": 2430000
            },
            {
                "label": "Less: Other comprehensive income attributable to Amneal Pharmaceuticals LLC pre-Combination",
                "concept": "amrx:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToAcquirerPriorToBusinessCombination",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Less: Other comprehensive loss (income) attributable to non-controlling interests",
                "concept": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 1394000
            },
            {
                "label": "Other comprehensive (loss) income attributable to Amneal Pharmaceuticals, Inc.",
                "concept": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
                "unit": "usd",
                "value": 1036000
            },
            {
                "label": "Comprehensive loss attributable to Amneal Pharmaceuticals, Inc.",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -63747000
            },
            {
                "label": "Net revenue",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 850762000
            },
            {
                "label": "Cost of goods sold",
                "concept": "CostOfGoodsAndServicesSold",
                "unit": "usd",
                "value": 606124000
            },
            {
                "label": "Cost of goods sold impairment charges",
                "concept": "amrx:CostOfGoodsAndServicesSoldImpairmentCharges",
                "unit": "usd",
                "value": 56309000
            },
            {
                "label": "Gross profit",
                "concept": "GrossProfit",
                "unit": "usd",
                "value": 188329000
            },
            {
                "label": "Selling, general and administrative",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 151717000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 101874000
            },
            {
                "label": "In-process research and development impairment charges",
                "concept": "AssetImpairmentCharges",
                "unit": "usd",
                "value": 22787000
            },
            {
                "label": "Intellectual property legal development expenses",
                "concept": "LegalFees",
                "unit": "usd",
                "value": 6677000
            },
            {
                "label": "Legal settlement gains",
                "concept": "GainLossRelatedToLitigationSettlement",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Acquisition, transaction-related and integration expenses",
                "concept": "amrx:BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense",
                "unit": "usd",
                "value": 9551000
            },
            {
                "label": "Restructuring and other charges",
                "concept": "RestructuringCharges",
                "unit": "usd",
                "value": 8996000
            },
            {
                "label": "Operating income (loss)",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -113273000
            },
            {
                "label": "Interest expense, net",
                "concept": "InterestIncomeExpenseNonoperatingNet",
                "unit": "usd",
                "value": -87167000
            },
            {
                "label": "Foreign exchange gain (loss), net",
                "concept": "ForeignCurrencyTransactionGainLossBeforeTax",
                "unit": "usd",
                "value": 2847000
            },
            {
                "label": "Loss on extinguishment of debt",
                "concept": "GainsLossesOnExtinguishmentOfDebt",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "(Loss) gain on sale of international businesses, net",
                "concept": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
                "unit": "usd",
                "value": 6930000
            },
            {
                "label": "Other income, net",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": 1256000
            },
            {
                "label": "Other (expense) income:",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": -76134000
            },
            {
                "label": "Loss before income taxes",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "unit": "usd",
                "value": -189407000
            },
            {
                "label": "Benefit from income taxes",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": -14129000
            },
            {
                "label": "Net loss per share attributable to Amneal Pharmaceuticals, Inc.'s common stockholders:",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.51
            },
            {
                "label": "Weighted-average shares of Class A Common Stock and Class B-1 Common Stock outstanding - basic and diluted (in shares)",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 127852000
            }
        ]
    }
}